Analystreport

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Aridis Pharmaceuticals Inc.  (ARDS) 
Last aridis pharmaceuticals inc. earnings: 11/13 04:05 pm Check Earnings Report